Deciphera Pharmaceuticals GAAP EPS of -$0.55 beats by $0.03, revenue of $35.97M beats by $2.96M

Nov. 03, 2022 7:06 AM ETDeciphera Pharmaceuticals, Inc. (DCPH)By: Dania Nadeem, SA News Editor
  • Deciphera Pharmaceuticals press release (NASDAQ:DCPH): Q3 GAAP EPS of -$0.55 beats by $0.03.
  • Revenue of $35.97M (+54.9% Y/Y) beats by $2.96M.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.